Literature DB >> 7897123

Comparison of secretion pattern between A-type and B-type natriuretic peptides in patients with old myocardial infarction.

H Sumida1, H Yasue, M Yoshimura, K Okumura, H Ogawa, K Kugiyama, K Matsuyama, K Kikuta, E Morita, K Nakao.   

Abstract

OBJECTIVES: The present study was designed to compare the secretion patterns of two cardiac hormones--A-type (atrial) and B-type (brain) natriuretic peptides--from the ventricles in patients with old myocardial infarction.
BACKGROUND: Plasma levels of these two natriuretic peptides are increased, and their secretion from the ventricles is augmented, in patients with congestive heart failure.
METHODS: We measured the plasma levels of these two types of natriuretic peptides at the aortic root and the anterior interventricular vein in 42 patients with old myocardial infarction (anterior in 22 and inferior in 20) and 18 control subjects.
RESULTS: The difference between the plasma levels of both A- and B-type natriuretic peptide in the anterior interventricular vein and aortic root was significantly greater in the groups with anterior and inferior infarction than in the control group (A-type [mean +/- SD] 380 +/- 290 and 247 +/- 205 pg/ml in the infarction groups vs. 11 +/- 14 pg/ml; B-type 497 +/- 445 and 75 +/- 73 pg/ml vs. 23 +/- 16 pg/ml, respectively). The difference between the plasma levels of each peptide at the anterior interventricular vein and aortic root had a significant negative linear correlation with left ventricular ejection fraction in both groups with infarction. The slope of the regression line of the arteriovenous difference of B-type natriuretic peptide at the anterior interventricular vein was significantly steeper in the anterior than in the inferior infarction group (left ventricular ejection fraction -12.801 vs. -1.891, p < 0.01).
CONCLUSIONS: These results indicate that 1) the secretion of A- and B-type natriuretic peptide from the left ventricular increases in proportion to the severity of left ventricular dysfunction, and 2) secretion of B-type natriuretic peptide is much greater from the infarct than from the noninfarct region, suggesting that the regional ventricular wall stretch caused by infarction strongly stimulates secretion of B-type natriuretic peptide.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7897123     DOI: 10.1016/0735-1097(94)00525-u

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  9 in total

1.  The role of the neurohormonal system in heart failure.

Authors:  M Komajda; F Pousset; R Isnard; P Lechat
Journal:  Heart       Date:  1998-06       Impact factor: 5.994

2.  Left ventricular remodelling and brain natriuretic peptide after first myocardial infarction.

Authors:  J G Crilley; M Farrer
Journal:  Heart       Date:  2001-12       Impact factor: 5.994

3.  Serial changes in plasma brain natriuretic peptide concentration at the infarct and non-infarct sites in patients with left ventricular remodelling after myocardial infarction.

Authors:  A Hirayama; H Kusuoka; H Yamamoto; Y Sakata; M Asakura; Y Higuchi; H Mizuno; K Kashiwase; Y Ueda; Y Okuyama; M Hori; K Kodama
Journal:  Heart       Date:  2005-03-17       Impact factor: 5.994

4.  Correlation between plasma brain natriuretic peptide concentration and lung thallium-201 uptake on exercise thallium perfusion images.

Authors:  Noriko Inoue; Nobukazu Takahashi; Kazuo Kimura; Toshiyuki Ishikawa; Shinichi Toyama; Yuzuru Yoshii; Kazuaki Uchino; Yohei Yamakawa; Katsumi Matsumoto; Tomio Inoue; Satoshi Umemura
Journal:  Heart Vessels       Date:  2006-03       Impact factor: 2.037

Review 5.  Clinical applications of N-terminal pro B-type natriuretic peptide in heart failure and other cardiovascular diseases.

Authors:  Da-Rong Pu; Jun R Chiong; Qi-chang Zhou
Journal:  Heart Fail Rev       Date:  2010-07       Impact factor: 4.214

6.  The synergistic combined effect of anemia with high plasma levels of B-type natriuretic peptide significantly predicts an enhanced risk for major adverse cardiac events.

Authors:  Hirofumi Ueno; Masafumi Nakayama; Sunao Kojima; Kenichi Kusuhara; Yasuhiro Nagayoshi; Megumi Yamamuro; Tsunenori Nishijima; Hiroki Usuku; Kouichi Kaikita; Hitoshi Sumida; Hiroshige Yamabe; Seigo Sugiyama; Michihiro Yoshimura; Hisao Ogawa
Journal:  Heart Vessels       Date:  2008-07-23       Impact factor: 2.037

7.  Cardiorenal status using amino-terminal pro-brain natriuretic peptide and cystatin C on cardiac resynchronization therapy outcomes: From the BIOCRT Study.

Authors:  Quynh A Truong; Jackie Szymonifka; James L Januzzi; Jigar H Contractor; Roderick C Deaño; Neal A Chatterjee; Jagmeet P Singh
Journal:  Heart Rhythm       Date:  2018-12-24       Impact factor: 6.343

Review 8.  Cardiac Natriuretic Peptides, Hypertension and Cardiovascular Risk.

Authors:  Riccardo Sarzani; Francesco Spannella; Federico Giulietti; Paolo Balietti; Guido Cocci; Marica Bordicchia
Journal:  High Blood Press Cardiovasc Prev       Date:  2017-04-04

9.  Plasma brain natriuretic peptide as a surrogate marker for cardioembolic stroke.

Authors:  Kazushi Yukiiri; Naohisa Hosomi; Takayuki Naya; Tsutomu Takahashi; Hiroyuki Ohkita; Mao Mukai; Hisashi Masugata; Koji Murao; Masaki Ueno; Takehiro Nakamura; Hiroaki Dobashi; Takanori Miki; Yasuhiro Kuroda; Masakazu Kohno
Journal:  BMC Neurol       Date:  2008-12-11       Impact factor: 2.474

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.